566 related articles for article (PubMed ID: 29603553)
21. Health-related quality of life and satisfaction with care among older men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy.
Jayadevappa R; Chhatre S; Whittington R; Bloom BS; Wein AJ; Malkowicz SB
BJU Int; 2006 May; 97(5):955-62. PubMed ID: 16643477
[TBL] [Abstract][Full Text] [Related]
22. Active Surveillance Versus Radical Prostatectomy in Favorable-risk Localized Prostate Cancer.
Thomsen FB; Røder MA; Jakobsen H; Langkilde NC; Borre M; Jakobsen EB; Frey A; Lund L; Lunden D; Dahl C; Brasso K
Clin Genitourin Cancer; 2019 Aug; 17(4):e814-e821. PubMed ID: 31196798
[TBL] [Abstract][Full Text] [Related]
23. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.
Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Ruutu M; Bill-Axelson A;
Lancet Oncol; 2011 Sep; 12(9):891-9. PubMed ID: 21821474
[TBL] [Abstract][Full Text] [Related]
24. The psychological aftermath of prostate cancer treatment choices: a comparison of depression, anxiety and quality of life outcomes over the 12 months following diagnosis.
Couper JW; Love AW; Dunai JV; Duchesne GM; Bloch S; Costello AJ; Kissane DW
Med J Aust; 2009 Apr; 190(S7):S86-9. PubMed ID: 19351300
[TBL] [Abstract][Full Text] [Related]
25. Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial.
Bill-Axelson A; Garmo H; Holmberg L; Johansson JE; Adami HO; Steineck G; Johansson E; Rider JR
Eur Urol; 2013 Dec; 64(6):920-8. PubMed ID: 23465517
[TBL] [Abstract][Full Text] [Related]
26. The accuracy of patients' perceptions of the risks associated with localised prostate cancer treatments.
van Stam MA; van der Poel HG; van der Voort van Zyp JRN; Tillier CN; Horenblas S; Aaronson NK; Ruud Bosch JLH
BJU Int; 2018 Mar; 121(3):405-414. PubMed ID: 28960827
[TBL] [Abstract][Full Text] [Related]
27. [The accuracy of patients' perceptions of the risks associated with localised prostate cancer treatments].
van Stam MA; Aaronson NK; van der Poel HG; van der Voort van Zyp JRN; Tillier CN; Horenblas S; Bosch JLHR
Ned Tijdschr Geneeskd; 2018 Jun; 162():. PubMed ID: 30040303
[TBL] [Abstract][Full Text] [Related]
28. Setting an Agenda for Assessment of Health-related Quality of Life Among Men with Prostate Cancer on Active Surveillance: A Consensus Paper from a European School of Oncology Task Force.
Villa S; Kendel F; Venderbos L; Rancati T; Bangma C; Carroll P; Denis L; Klotz L; Korfage IJ; Lane AJ; Magnani T; Mastris K; Rannikko A; Roobol M; Trock B; Van den Bergh R; Van Poppel H; Valdagni R; Bellardita L
Eur Urol; 2017 Feb; 71(2):274-280. PubMed ID: 27720532
[TBL] [Abstract][Full Text] [Related]
29. A prospective study of health-related quality of life outcomes among men treated for intermediate- and high-risk prostate cancer: the impact of primary and secondary therapies.
Alsinnawi M; Cullen J; Hurwitz LM; Levie KE; Burns JF; Rosner IL; Brand TC; Stroup S; Sterbis JR; Rice K; Conti G; Porter CR
Can J Urol; 2019 Aug; 26(4):9809-9820. PubMed ID: 31469635
[TBL] [Abstract][Full Text] [Related]
30. Generalizability of the Prostate Cancer Intervention Versus Observation Trial (PIVOT) Results to Contemporary North American Men with Prostate Cancer.
Dalela D; Karabon P; Sammon J; Sood A; Löppenberg B; Trinh QD; Menon M; Abdollah F
Eur Urol; 2017 Apr; 71(4):511-514. PubMed ID: 27638094
[TBL] [Abstract][Full Text] [Related]
31. Development and Internal Validation of a Web-based Tool to Predict Sexual, Urinary, and Bowel Function Longitudinally After Radiation Therapy, Surgery, or Observation.
Laviana AA; Zhao Z; Huang LC; Koyama T; Conwill R; Hoffman K; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg MR; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Penson DF; Barocas DA
Eur Urol; 2020 Aug; 78(2):248-255. PubMed ID: 32098731
[TBL] [Abstract][Full Text] [Related]
32. A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer.
Wolff RF; Ryder S; Bossi A; Briganti A; Crook J; Henry A; Karnes J; Potters L; de Reijke T; Stone N; Burckhardt M; Duffy S; Worthy G; Kleijnen J
Eur J Cancer; 2015 Nov; 51(16):2345-67. PubMed ID: 26254809
[TBL] [Abstract][Full Text] [Related]
33. Radical prostatectomy vs radiation therapy and androgen-suppression therapy in high-risk prostate cancer.
Westover K; Chen MH; Moul J; Robertson C; Polascik T; Dosoretz D; Katin M; Salenius S; D'Amico AV
BJU Int; 2012 Oct; 110(8):1116-21. PubMed ID: 22540922
[TBL] [Abstract][Full Text] [Related]
34. Impact on quality of life 3 years after diagnosis of prostate cancer patients below 75 at diagnosis: an observational case-control study.
Houédé N; Rébillard X; Bouvet S; Kabani S; Fabbro-Peray P; Trétarre B; Ménégaux F
BMC Cancer; 2020 Aug; 20(1):757. PubMed ID: 32787797
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer.
Wei JT; Dunn RL; Sandler HM; McLaughlin PW; Montie JE; Litwin MS; Nyquist L; Sanda MG
J Clin Oncol; 2002 Jan; 20(2):557-66. PubMed ID: 11786586
[TBL] [Abstract][Full Text] [Related]
36. Health-related quality of life and psychosocial factors in patients with prostate cancer scheduled for radical prostatectomy or external radiation therapy.
Van Andel G; Visser AP; Hulshof MC; Horenblas S; Kurth KH
BJU Int; 2003 Aug; 92(3):217-22. PubMed ID: 12887470
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal regret after treatment for low- and intermediate-risk prostate cancer.
Hurwitz LM; Cullen J; Kim DJ; Elsamanoudi S; Hudak J; Colston M; Travis J; Kuo HC; Rice KR; Porter CR; Rosner IL
Cancer; 2017 Nov; 123(21):4252-4258. PubMed ID: 28678408
[TBL] [Abstract][Full Text] [Related]
38. Health-related quality of life among long-term (≥5 years) prostate cancer survivors by primary intervention: a systematic review.
Adam S; Feller A; Rohrmann S; Arndt V
Health Qual Life Outcomes; 2018 Jan; 16(1):22. PubMed ID: 29361950
[TBL] [Abstract][Full Text] [Related]
39. Health-Related Quality of Life Changes in Prostate Cancer Patients after Radical Prostatectomy: A Longitudinal Cohort Study.
Shin DW; Lee SH; Kim TH; Yun SJ; Nam JK; Jeon SH; Park SC; Jung SI; Park JH; Park J
Cancer Res Treat; 2019 Apr; 51(2):556-567. PubMed ID: 30011984
[TBL] [Abstract][Full Text] [Related]
40. Impact of hormonal therapy prior to radical prostatectomy on the recovery of quality of life.
Namiki S; Saito S; Tochigi T; Kuwahara M; Ioritani N; Yoshimura K; Terai A; Koinuma N; Arai Y
Int J Urol; 2005 Feb; 12(2):173-81. PubMed ID: 15733112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
